Federal cuts to PBTC reduce immediate trial options for pediatric brain tumors. NCI shifts trial oversight to PEP-CTN, ending PBTC funding by March 2026. Specialists warn the reorganization limits ...
Breakthrough research identifies TIM3 as a key target in MAPK-activated pediatric gliomas, offering new hope for more effective immunotherapy treatments. Despite being a leading cause of childhood ...
Brain tumors are the leading cause of pediatric cancer-related death. In August, the Trump administration announced it would stop supporting a federally funded network dedicated to researching these ...
A network dedicated to early phase trials of treatments for children with brain cancer will be phased out. By Nina Agrawal A respected network of hospitals and cancer centers is halting enrollment in ...
PHILADELPHIA, Nov. 21, 2025 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) and Children's National Hospital in Washington D.C. are uncovering how rare inherited genetic ...
Neurons (green) and tumor cells (cyan) grown in a lab demonstrate how the two cell types can become interconnected as a tumor grows, disrupting brain development and function. New research from WashU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results